Muram D - Search Results

1

Validation of a two-item quantitative questionnaire for the triage of women with urinary incontinence.

Bent AE, Gousse AE, Hendrix SL, Klutke CG, Monga AK, Yuen CK, Meadows ES, Yalcin I, Muram D; Duloxetine Mixed Urinary Incontinence Study Group. Bent AE, et al. Among authors: muram d. Obstet Gynecol. 2005 Oct;106(4):767-73. doi: 10.1097/01.AOG.0000178168.33249.49. Obstet Gynecol. 2005. PMID: 16199634

2

Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence.

Bent AE, Gousse AE, Hendrix SL, Klutke CG, Monga AK, Yuen CK, Muram D, Yalcin I, Bump RC. Bent AE, et al. Among authors: muram d. Neurourol Urodyn. 2008;27(3):212-21. doi: 10.1002/nau.20471. Neurourol Urodyn. 2008. PMID: 17580357 Clinical Trial.

3

Duloxetine in the treatment of women with stress urinary incontinence: results from DESIRE (Duloxetine Efficacy and Safety for Incontinence in Racial and Ethnic populations).

Weinstein DL, Cohen JS, Liu C, Meadows ES, Plouffe L Jr, Muram D; DESIRE Study Group. Weinstein DL, et al. Among authors: muram d. Curr Med Res Opin. 2006 Nov;22(11):2121-9. doi: 10.1185/030079906X148337. Curr Med Res Opin. 2006. PMID: 17076972 Clinical Trial.

4

Rationale for a non-inferiority clinical trial design focused on subpopulations.

Kulkarni PM, Meadows ES, Ahuja S, Muram D, Plouffe L Jr. Kulkarni PM, et al. Among authors: muram d. Curr Med Res Opin. 2004 Oct;20(10):1641-7. doi: 10.1185/030079904X4392. Curr Med Res Opin. 2004. PMID: 15462697

5

Incidence of urinary incontinence in postmenopausal women treated with raloxifene or estrogen.

Goldstein SR, Johnson S, Watts NB, Ciaccia AV, Elmerick D, Muram D. Goldstein SR, et al. Among authors: muram d. Menopause. 2005 Mar;12(2):160-4. doi: 10.1097/00042192-200512020-00010. Menopause. 2005. PMID: 15772563

6

Urinary retention secondary to a Gartner's duct cyst.

Muram D, Jerkins GR. Muram D, et al. Obstet Gynecol. 1988 Sep;72(3 Pt 2):510-1. Obstet Gynecol. 1988. PMID: 3405570

7

The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety.

Stovall DW, Utian WH, Gass ML, Qu Y, Muram D, Wong M, Plouffe L Jr. Stovall DW, et al. Among authors: muram d. Menopause. 2007 May-Jun;14(3 Pt 1):510-7. doi: 10.1097/GME.0b013e318031a83d. Menopause. 2007. PMID: 17314736 Clinical Trial.

8

Patient characteristics and utilization of breast cancer screening or diagnostic procedures prior to initiation of raloxifene, bisphosphonates and calcitonin.

Foster SA, Whangbo A, Mitchell B, Muram D, Mershon JL, Kar R, Vedarajan G. Foster SA, et al. Among authors: muram d. Curr Med Res Opin. 2010 Nov;26(11):2521-6. doi: 10.1185/03007995.2010.515456. Epub 2010 Sep 15. Curr Med Res Opin. 2010. PMID: 20843165

9

Skin reactions in a phase 3 study of a testosterone topical solution applied to the axilla in hypogonadal men.

Muram D, Melby T, Alles Kingshill E. Muram D, et al. Curr Med Res Opin. 2012 May;28(5):761-6. doi: 10.1185/03007995.2012.681034. Epub 2012 Apr 18. Curr Med Res Opin. 2012. PMID: 22458919 Clinical Trial.

10

Utility of a single serum testosterone measurement to determine response to topical testosterone replacement in hypogonadal men.

Muram D, Ni X. Muram D, et al. Curr Med Res Opin. 2016;32(2):263-9. doi: 10.1185/03007995.2015.1117434. Epub 2015 Dec 15. Curr Med Res Opin. 2016. PMID: 26549704 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters